Daiken Biomedical Co., Ltd.

7780 · TW · Consumer Defensive / Packaged Foods

15.10TWD+0.20 (+1.34%)

Price History

Full chart

Market Stats

Previous Close14.90

Open14.95

Day Range14.95 – 15.15

52-Week Range15.06 – 181.58

Volume465.36K

Market Cap12.93B

P/E (TTM)160.50

Forward P/E0.00

EPS0.10

Dividend Yield8.35%

50-Day Avg16.58

200-Day Avg22.51

About

Daiken Biomedical Co., Ltd. engages in the research and development of healthy food products. The company was founded in 2018 and is based in Taipei, Taiwan. Daiken Biomedical Co., Ltd. operates as a subsidiary of Sunfun Info Co., Ltd.

Company Details

SectorConsumer Defensive
IndustryPackaged Foods
CEOMr. Tung-Ching Lin
HeadquartersNo. 37, Section 3, Roosevelt Road, Taipei, Taiwan, 106, Taiwan
Websitehttps://certifications.nutrasource.ca/certified-pr

Leadership

Mr. Tung-Ching LinChairman & Manager

Financials

Income Statement

Currency: TWD	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Revenue	884.97M	1.19B	1.36B	1.90B
Growth (%)	-	+34.52%	+14.45%	+39.10%
Cost of Revenue	271.66M	376.66M	506.17M	689.36M
Gross Profit	613.30M	813.76M	856.22M	1.21B
Gross Margin	69.30%	68.36%	62.85%	63.62%
Operating Expense	500.86M	609.60M	706.42M	917.49M
Operating Income	112.44M	204.15M	149.80M	288.24M
Operating Margin	12.71%	17.15%	11.00%	15.21%
EBITDA	110.82M	199.63M	149.82M	425.03M
EBITDA Margin	12.52%	16.77%	11.00%	22.43%
Net Income	90.17M	160.35M	106.58M	337.87M
Net Income Margin	10.19%	13.47%	7.82%	17.83%
R&D	7.36M	7.82M	10.16M	11.28M
R&D as % of Total Revenue	0.83%	0.66%	0.75%	0.60%
Interest Expense	1.18M	3.36M	6.00M	595.00K
Interest Expense % of Total Revenue	0.13%	0.28%	0.44%	0.03%

Balance Sheet

Currency: TWD	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Assets	530.16M	745.17M	1.54B	5.91B
Total Liabilities	302.74M	497.85M	230.81M	469.95M
Total Equity	227.43M	247.32M	1.31B	5.44B
Cash	243.71M	287.06M	1.14B	2.24B

Cash Flow

Currency: TWD	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Operating Cash Flow	41.58M	105.20M	51.75M	272.59M
Capital Expenditure	53.00K	0	3.22M	3.78M
Free Cash Flow	41.53M	105.20M	48.53M	268.81M
Dividends Paid	-	140.46M	3.08M	589.23M
FCF to OCF	99.87%	100.00%	93.77%	98.61%
Dividend Paid to FCF	-	133.51%	6.35%	219.20%

Earnings

Report Date	Nov 7, 2025	Mar 9, 2026	May 7, 2026
EPS Estimate	0.07	0.16	0.09
EPS Actual	0.11	0.17	0.00
Surprise	57.14%	6.25%	-100.00%
Timing	Pre-market	Pre-market	Pre-market

Key Statistics & Ratios

Market Cap12.93B

Enterprise Value7.91B

Trailing P/E160.50

Forward P/E0.00

Price / Sales5.92

Price / Book2.68

EPS0.10

Book Value6.05

Revenue (TTM)2.19B

Gross Profit (TTM)1.35B

EBITDA400.99M

Profit Margin19.44%

Operating Margin20.28%

Return on Equity14.22%

Return on Assets6.26%

Shares Outstanding805.56M

Shares Float215.50M

Dividend Yield8.35%

Dividend Rate1.34

Payout Ratio3.91%

Dividends

20262×

0.12Sep 3, 20260.89Jun 22, 2026

20255×

0.08Nov 24, 20250.25Aug 25, 20250.16Jul 22, 20250.33Jun 17, 20250.07Feb 26, 2025

Stock Splits

Jan 9, 202610000:1000